Activity Dates: 04/01/2021 - 02/24/2024
This course is designed for pharmacists, nurse practitioners or other health care professionals involved in the comprehensive medication management of psychiatric and/or neurological patients.
This program is the self-study, enduring version of the pre-meeting workshop from CPNP 2021. With presentations from expert faculty members (Drs. Jeff Bishop and Vicki Ellingrod), case-based learning, and group discussion, novice learners in the area of PGx can build and enhance their understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans. It is clear there has been significant growth in the use of pharmacogenomics (PGx) testing applied to the prescribing of psychiatric medications. Patients and providers may be unfamiliar with PGx tests, including resources available to aid in interpretation, as well as how to effectively communicate with patients and other providers about the reasons to (or not to test) and interpretation of the results. With the event of direct to consumer testing options, providers may also be uncertain of what to do when presented with a testing result, including understanding the evidence behind the results included. Furthermore, providers may not be comfortable counseling patients on PGx results due to their lack of direct experience with the tests. Therefore, this program will be geared toward the novice learner with intent to build and enhance pharmacists’ understanding of the current state of evidence for incorporating pharmacogenomics into patient care plans.
You will proceed through the following steps to satisfactorily complete this course:
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.
CPNP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access CPNP course materials online, you will need:
CPNP web sites no longer fully support Microsoft Internet Explorer 9 and older or Windows 7 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Jeffrey R. Bishop, PharmD, MS, BCPP, FCCP
Vicki L. Ellingrod, PharmD, FCCP
The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of CPNP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Presentation-Specific Disclosure: My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: Portions of the presentation will discuss pharmacogenetic information not included in drug labeling.
It is the policy of CPNP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CPNP for any product or manufacturer identified.